Subodh Kumar

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Cognitive Decline

Top Venues

Pharmaceuticals (Basel, Switzerland)

Neuroscience insights

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Gayatri Reddy Aaluri, Yashmit Choudhary, Subodh Kumar
Mitochondria-Associated MicroRNAs and Parkinson's Disease. Neuroscience insights 19 (2024)
Gayatri Reddy Aaluri, Yashmit Choudhary, Subodh Kumar
Mitochondria-Associated MicroRNAs and Parkinson's Disease. Neuroscience insights 19 (2024)
Jazmin Rivera, Laxman Gangwani, Subodh Kumar
Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer's Disease and Aging. Cells 12 (5) (2023)
Davin Devara, Yashmit Choudhary, Subodh Kumar
Role of MicroRNA-502-3p in Human Diseases. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Davin Devara, Yashmit Choudhary, Subodh Kumar
Role of MicroRNA-502-3p in Human Diseases. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Jazmin Rivera, Laxman Gangwani, Subodh Kumar
Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer's Disease and Aging. Cells 12 (5) (2023)
Davin Devara, Yashmit Choudhary, Subodh Kumar
Role of MicroRNA-502-3p in Human Diseases. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Jazmin Rivera, Laxman Gangwani, Subodh Kumar
Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer's Disease and Aging. Cells 12 (5) (2023)
Davin Devara, Yashmit Choudhary, Subodh Kumar
Role of MicroRNA-502-3p in Human Diseases. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Jazmin Rivera, Laxman Gangwani, Subodh Kumar
Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer's Disease and Aging. Cells 12 (5) (2023)
Ashutosh Khaswal, Vivek Kumar, Subodh Kumar
Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections. Diagnostics (Basel, Switzerland) 12 (8) (2022)
Sudhir Kshirsagar, Rainier Vladlen Alvir, Jangampalli Adi Pradeepkiran, Ashly Hindle, Murali Vijayan, Bhagavathi Ramasubramaniam, Subodh Kumar, Arubala P Reddy, P Hemachandra Reddy
A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer's Disease. Cells 11 (17) (2022)